MRNA
Moderna, Inc.Company with tickers: MRNA
CIK
1682852
CUSIP
60770K107
Shares Outstanding
396,786,259
Website
https://www.modernatx.com
Investor Relations
https://investors.modernatx.com/
13F Activity (30d)
57 filings
15 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$1,700,000,000
as of 2026-03-31
Remaining Authorization
$1,667,000,000
as of 2025-12-31
Program Utilization
1.9%
$33,000,000 used of $1,700,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2025-12-31 | $2,000,000 | 10-K, filed 2026-02-20 | ||
| 2024-12-31 | $0 | 10-K, filed 2026-02-20 | ||
| 2023-12-31 | $1,153,000,000 | 10-K, filed 2026-02-20 | ||
| 2022-12-31 | $3,329,000,000 | 10-K, filed 2025-02-21 | ||
| 2021-12-31 | $857,000,000 | 10-K, filed 2024-02-23 | ||